Method for differentiating mesenchymal stem cells into neural cells
Patent Number: 7,229,827
Date of First Priority Issue: Thursday April 19th, 2001
Date Issued: Tuesday June 12th, 2007
Assignee: FCB-Pharmicell Co., Ltd. (KR); LifeCord International Co., Ltd. (KR)
Inventors: Kim; Hyun-Soo (Suwon, KR), Yoon; Hee-Hoon (Incheon, KR)
From Class: Differentiation
Comments: No comments
Mesenchymal stem cells are currently in Phase III of clinical trials by companies such as Osiris. Additionally, numerous academic institutions are conducting clinical trials for mesenchymal stem cells.
The current patent covers the differentiation of mesenchymal stem cells into neurons by culture with FGF-2, HGF, and EGF. This patent could be very useful once Osiris starts selling mesenchymal stem cells as an off the shelf product because at that time scientists can simply purchase them, differentiate them into neurons, and use for treating neurological disorders.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday June 17th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.